Cargando…
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals
Patients with metastatic renal cell cancer (mRCC) who respond to upfront immune checkpoint inhibitor (ICI) combination therapies may be treated with cytoreductive nephrectomy (CN) to remove radiographically viable primary tumors. Early data for post-ICI CN suggested that ICI therapies induce desmopl...
Autores principales: | Shapiro, Daniel D., Karam, Jose A., Zemp, Logan, Master, Viraj A., Sexton, Wade J., Ghasemzadeh, Ali, Schmeusser, Benjamin N., Davaro, Facundo, Peak, Taylor, Patil, Dattatraya, Matin, Surena, Spiess, Philippe E., Abel, E. Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969293/ https://www.ncbi.nlm.nih.gov/pubmed/36861106 http://dx.doi.org/10.1016/j.euros.2023.01.016 |
Ejemplares similares
-
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
por: Baum, Yoram S., et al.
Publicado: (2016) -
Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2022) -
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021) -
Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy
por: Leone, Andrew, et al.
Publicado: (2016) -
Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma
por: Midenberg, Eric R., et al.
Publicado: (2022)